Agile Therapeutics (AGRX)
US Market

Agile Therapeutics (AGRX) Financial Statements


Agile Therapeutics Financial Overview

Agile Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.653; its P/E ratio is -0.09; Agile Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 5.72M$ 6.66M$ 3.20M$ 3.81M$ 4.00M
Gross Profit$ 4.04M$ 4.18M$ 3.20M$ 1.81M$ 2.34M
EBIT$ 1.47M$ -458.00K$ -3.44M$ -4.99M$ 18.64M
EBITDA$ 1.57M$ -360.00K$ -3.34M$ -4.89M$ 18.73M
Net Income Common Stockholders$ 1.28M$ -799.00K$ -3.81M$ -5.39M$ 18.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.62M$ 2.87M$ 2.79M$ 4.43M$ 5.25M
Total Assets$ 12.61M$ 10.89M$ 12.57M$ 13.70M$ 14.24M
Total Debt$ 378.00K$ 2.14M$ 2.19M$ 2.22M$ 2.21M
Net Debt$ -2.24M$ -735.00K$ -593.00K$ -2.21M$ -3.04M
Total Liabilities$ 22.93M$ 23.30M$ 24.69M$ 23.13M$ 19.79M
Stockholders Equity$ -10.32M$ -12.41M$ -12.12M$ -9.43M$ -5.54M
Cash Flow-
Free Cash Flow$ -2.48M$ 365.00K$ -8.52M$ -1.59M$ -1.56M
Operating Cash Flow$ -2.48M$ 365.00K$ -8.52M$ -1.59M$ -1.56M
Investing Cash Flow-----
Financing Cash Flow$ 2.54M$ 1.38M$ 6.88M$ 778.00K$ 660.00K
Currency in USD

Agile Therapeutics Earnings and Revenue History

Agile Therapeutics Debt to Assets

Agile Therapeutics Cash Flow

Agile Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis